(Adnkronos) – SAN MATEO, Calif., March 8, 2023 /PRNewswire/ — Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces a grant award of US$2,500,000 from The Michael J.
>>> vai all'articolo completo
